+499.5%
MRNA vs QSR
+33.2%
+466.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | QSR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.1% | -2.1% | -2.2% |
| 7D | +5.5% | +2.4% | +3.0% | +4.4% |
| 30D | +158.7% | +7.6% | +151.1% | +151.3% |
| 3M | +182.1% | +12.6% | +169.5% | +168.1% |
| 6M | +151.8% | +14.4% | +137.4% | +135.4% |
| YTD | +393.6% | +19.6% | +373.9% | +342.4% |
| 1Y | +499.5% | +33.9% | +465.6% | +361.8% |
| All | +499.5% | +33.2% | +466.2% | +361.8% |
Cumulative growth
Daily Returns
Daily percentage return beside QSR.
Daily Out/Under-Performance
Portfolio return minus QSR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × QSR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded QSR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling